chrisvoncsefalvay/vaers-outcomes huggingface dataset:
the patient was administered a dose of improperly stored PROQUAD; no adverse effects reported; This spontaneous report has been from a nurse concerning a patient of unknown age gender and ethnicity.   The patient's concurrent conditions, medical history and drug reactions or allergies were not reported. Concomitant medications included sterile diluent.  On an unspecified date, the patient received a dose of improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHA) (PROQUAD) (product storage error) (dose number, route of administration and anatomical location were not reported) (lot #: R030799, expiration date: 22-APR-2020) as prophylaxis. The temperature was in the range of 15 degrees Fahrenheit to 46 degrees Fahrenheit (40.9 degrees Fahrenheit) for a total time frame of 50 minutes. There were no previous temperature excursions. The call was because of a data logger. No adverse effects were reported.
Progressive fatigue, mental cloudiness, headaches, SOB/DOE, ultimately leading to an episode of syncope on 7/10/21. etiology for syncope still pending, concerning for cardiogenic, seizure, other?
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose12/18/21 2nd dose01/07/21 Diagnosed covid positive: Symptom onset:08/31/21 ExposurE;HOME Symptoms:fever, cough,muscleaches,runnynose,HA
arm is killing her; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm is killing her) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.No Medical History information was reported.In January 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 15-Nov-2021, the patient experienced VACCINATION SITE PAIN (arm is killing her). At the time of the report, VACCINATION SITE PAIN (arm is killing her) outcome was unknown. No concomitant and treatment information were reported by the reporter.The date of the first Moderna COVID-19 dose was unknown.This case was linked to MOD-2021-389053 (Patient Link).
2/25/2021- Admitted to hospital following severe high-grade fevers and headaches.  Received her second dose of Pfizer COVID vaccine on 2/24/2021.  Reported fevers as high as 105 at home.  Admitted for IV hydration.  Her fever persisted 24 hours after admission and headaches got worse.  Patient started on Topamax with better control of headaches.  Fever subsided 24 hours prior to discharge.  Discharge home on 2/28/2021.
Redness & some swelling at injection site 8 days later.  Gone within 2 days. No treatment needed.  Reporting this for information only.
606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  HCP reported that there was a confusion between the expiration date printed in the carton and the expiration date when the quick response code scanned. No temperature excursions was noted. No adverse events were noted. The vaccine was placed in refrigerator on 05-Nov-2021.  Treatment information was not provided by the reporter.
pt recv vax 13MAY97 & 13JUN97 & pt exp muscle pain & lack of muscle control described as very similar to numbness when one's arm falls asleep;to approx 30min to regain full use of arm which was sore;also exp pain in rt arm @ inj site;
Felt immobilized, extreme fatigue, slight fever, loss of appetite, and chills. Symptoms lasted about 24-36 hours after vaccination.
she is 10 days overdue for her second Shingrix vaccine; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose 0.5 ml intramuscularly in unknown arm in February 2023).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: she is 10 days overdue for her second Shingrix vaccine).  The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 28-AUG-2023 The patient self-reported this case. The reporter did not consent to follow-up. Till the time of reporting the patient did not receive the 2nd dose of Shingrix which led to incomplete course of vaccination.
p/vax rt thigh devel 4-5 large red welts;area hot to touch;rx DPH & ice applied;lt thigh became very red;
Chest tightness, dizziness, fatigue, hemoptysis x1, left side head pain, shortness of breath x 7 days.
Tested positive for COVID 11/12/2021.  Dx admission COVID-10 pneumonia. This patient was admitted to the emergency room because of difficulty breathing.  The patient was tested positive for COVID-19.  The patient has been sick for almost over a week, where he was having nonproductive cough and pleuritic chest pain with difficulty, increase in nature along with generalized fatigue and weakness. SOB on exertion. Treatment:  Decadron, Lovenox, Stable.  Discharged to home.
pt awoke from nap 10JUL93 w/unconsolable crying from 4PM-6PM & cont to cry off & on til Sunday 12N when went to ER; taken only 2 1/2 oz formula for SAT 4PM; pt fussy & not eating;
Generalized macular/papular rash, concentrated on trunk which progressed to vesicles and resolved in 5 days.
This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about concomitant medication, pertinent medical history and drug reactions/allergies was not provided. On 22-OCT-2018, the patient was vaccinated with improperly stored RECOMBIVAX HB (lot # R001084, expiration date 07-NOV-2020) for prophylaxis (strength, dose detail, anatomical location and route of administration were not reported). No adverse effect was reported. The vaccine was exposed to temperature excursion between 0 degree Celsius (C) and 1 degree C for a time frame of 19 minutes and between 9 degree C and 25 degree C for 1 hour without previous temperature excursion. Data logger was involved. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1901USA001125:
5 days after vaccine, I started my period. This is 2 weeks earlier than normal and I?m always regular. The blood was bright red and atypical. Period was heavy and now tapering after 4 days. No warning or other Typical Menstrual signs or symptoms.
Ongoing, beginning two days after injection. In addition to injection site/arm soreness, began to experience a constant tightness (cramp-like) within the left side of torso, like the muscles around heart or lung is cramping. Unable to take a full inhale of breath without discomfort/pain.
This spontaneous report as received from a pharmacist refers to a 60 year old female patient. No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On 11-APR-2016 (reported as "today"), the patient was vaccinated with an expired dose of ZOSTAVAX, which had a lot # of L029480 and an expiration date of 16-MAR-2016 (dose, dosage number, route of administration and anatomical location were not reported). However, no adverse effects were reported. Additional information is not expected since consent to be contacted for follow up information was not provided.
Vial initially stored in refrigerator on 04-Jun-2022 and administered on 30-Jul-2022; No adverse event; Administered the vaccine to 346 patients after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 04-Jun-2022 and administered on 30-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 23-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 30-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 30-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 04-Jun-2022 and administered on 30-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 04-Jun-2022 and administered on 30-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 04-Jun-2022 and administered on 30-Jul-2022).    Concomitant medication information was not provided by the reporter.  Patient received half dose.  Vial was initially stored in the refrigerator on 04-Jun-2022.  Vaccine administered to 346 patients after the 30 day by used involved 35 vials. Vial did not undergone any temperature excursions.  Treatment information was not provided by the reporter.
During a stressful time in my life, on the night of April 30th 2021, I developed skipped and irregular heart beats, which I thought were PVCs (premature ventricular contractions). PVCs were confirmed on May 18th, 2021 as outflow (normal type) PVCs by Dr., electrophysiologist at medical office in state. I still have PVCs and today's date is 9/6/2021. I am currently not under stress.
Passed out for a total of three times; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (Passed out for a total of three times) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced LOSS OF CONSCIOUSNESS (Passed out for a total of three times) (seriousness criterion medically significant). At the time of the report, LOSS OF CONSCIOUSNESS (Passed out for a total of three times) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (COVID 19 Vaccine) (unknown route), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.  The patient received the Moderna COVID-19 vaccine and exactly two days later the patient passed out. The patient passed out for a total of three times after receiving the Moderna vaccine.  Company comment: This case concerns a patient of an unknown age and gender with no medical history provided, who experienced the serious unexpected event of Loss of consciousness. Reportedly, the event occurred two days following the administration of the mRNA-1273 vaccine. At the time of this report, it was stated that the patient passed out for a total of three times. The dose of the vaccine and the exact dates were not specified. The outcome of the event was also not provided. The re-challenge is not applicable since no information about the dose number was disclosed and the outcome of the event was unknown. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This case concerns a patient of an unknown age and gender with no medical history provided, who experienced the serious unexpected event of Loss of consciousness. Reportedly, the event occurred two days following the administration of the mRNA-1273 vaccine. At the time of this report, it was stated that the patient passed out for a total of three times. The dose of the vaccine and the exact dates were not specified. The outcome of the event was also not provided. The re-challenge is not applicable since no information about the dose number was disclosed and the outcome of the event was unknown. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.
Swollen lymph nodes on left side under arm and on collarbone.  I had this reaction after the 2nd dose but my reaction was alot worse than I am experiencing now.
Patient received a Tdap in right arm on 8/17/15 then on 8/18/15 she developed fatigue and body achiness. States her right arm is more achy than other areas of her body. Patient seen by doctor on 8/18/15.
Rash and fever began two days after administration of vaccines; diagnosed with chickenpox at local ER, confirmed with in office pediatrician
Shortness of breath, chest tightness, and tightness in throat, c/o dizziness, hives, rash at site of injection, starting approx. 10 min. after vax. ER observed, symtoms abated before she was released. She refused any tx. with medications.
Anxiety 24 hours after my vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety 24 hours after my vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANXIETY (Anxiety 24 hours after my vaccine). At the time of the report, ANXIETY (Anxiety 24 hours after my vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.  Treatment medications were not reported.  It was stated that the patient Can I take 0.25 Xanax for anxiety 24 hours after my vaccine.   Reporter did not allow further contact
Approximately 30 minutes after receiving flu vaccine, chills, general malaise and joint pain, blister on lower lip, night seats, with intermittent chills, nausea, gelatinous stools.
Information has been received from a nurse referring to unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored (Merck) PROQUAD injection (lot # L026728, expiration date 15-JAN-2017) (dose and route were not reported). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Increase body temperature of 100.0, chills, headache, fatigue on 12/27/20-12/29/20
Patient was vaccinated with Covid booster, and upon getting back home her shoulder was hurting. She called the pharmacy back to speak with RPH. After coming back into the pharmacy RPH advised patient to go to doctor to get evaluated. Patient complained of shoulder pain and limited range of motion. Patient reported to the emergency room and was released. Patient followed up with primary care prescriber the following week. Patient still reporting shoulder pain the following week including that it was hard to complete tasks around her farm and it was still hard to get dressed.  Patient is doing physical therapy and strength exercises.
17MAR94 pt phoned c/o knot in lt arm site of flu shot 1OCT93; states had itching & reddness @ inject site for 2 days p/inject but subsided; was seen 18APR94: imp 1) r/o erythema nodosum ? etiology; 2) r/o arthus rxn;
Approximately 10 hrs after vaccination (pt had nasal congestion but no fever or cough), pt had 2 generalized tonic clonic seizures. Taken to ED. Admitted to PICU. 3mo exFT previously healthy baby presenting with new onset seizures. Has had rhinorrhea and mild cough last few days but feeding, voiding (x10 daily), stooling (x2 daily), regularly. Received his 2 month shots on day of admission (per parents 2 shots and one oral), and was a little fussier than usual afterwards so mom gave TYLENOL x2 at home. No fevers at home however. Woke up from sleep and around 8pm noted to have full body GTC seizures with mouth foaming, unresponsive, blank stare that lasted about 1 minute. Acted normally afterwards until developed second seizure x1 minute similar to the first, en route to the hospital. No sick contacts, emesis, diarrhea, rashes. Traveled over weekend but no foreign travel. Unremarkable birth history. NICU admission (8/21/-8/22/15) for sepsis workup at 12 days old. Per parents at this time he had a few episodes of "intense shiver" that lasted a few seconds but they didn't think anything of. Had AGE symptoms at the time so brought him to ED. Sepsis ruled out and presumed to have milk protein allergy. Feeds on alimentum since diagnosed with milk protein allergy. Takes about 4 oz q1h. Feeding normally today.
Fever 102, headache, lethargy, emesis, body aches. Tylenol, Motrin.
Suspected vaccination failure; got shingles three times. The worst one was in his groin; very very painful!; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient's wife reported the case. The age at vaccination was not reported. The reporter stated that, the patient was not safe by getting the shot. The patient had the shot and after that he got shingles three times. The worst one was in his groin very very painful. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for herpes zoster were not provided.
atrial fibrillation episodes; can't walk very well (limping) due to stiffness; unable to move her hands; muscles are stiff; ongoing watery diarrhea; terrible arthritis throughout her whole body; swollen armpit with a growth; sore left arm; headaches; A spontaneous report was received from a consumer who was a 73-year-old, female patient who received Moderna's covid-19 vaccine (mRNA-1273) and experienced sore left arm (vaccination site pain), headache, terrible arthritis throughout her whole body (arthralgia), unable to move her hands, muscles are stiff, ongoing watery diarrhea, a swollen armpit with a growth (vaccination site lymphadenopathy), she can't walk very well (limping) due to stiffness and atrial fibrillation episodes.  The patient's medical history includes cancer of the bowels five years ago, heart problems and arthritis.  Concomitant medications reported as amlodipine besylate (2.5 mg daily), rivaroxaban (20 mg daily), Preservision, organic whole food multi-vitamins, and marijuana.  On 27-JAN-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 007M20A) intramuscularly in the left arm for prophylaxis of Covid-19 infection.   On 27-JAN-2021, the patient reported that her left arm was sore and that she had headaches that started six hours after the injection and lasted for seven or eight days.  Additionally, the patient reported several other symptoms for which the start date was unknown including arthritis throughout her entire body, the inability to move her hands, stiff muscles, watery diarrhea and a swollen armpit with a growth.  She also reported that she was limping due to stiffness and was having atrial fibrillation episodes.  No additional data regarding the atrial fibrillation episodes was provided.   Laboratory details were not provided.   Treatment for the events included paracetamol and naproxen.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the event, headaches, was considered recovered/resolved.  The outcomes of the events, sore left arm (vaccination site pain), terrible arthritis throughout her whole body (arthralgia), unable to move her hands, muscles are stiff, ongoing watery diarrhea, a swollen armpit with a growth (vaccination site lymphadenopathy), she can't walk very well (limping) due to stiffness and atrial fibrillation episodes, were considered unknown.; Reporter's Comments: This case concerns a 73 Y/O F with serious unexpected atrial fibrillation and NS unexpected diarrhea, muscular weakness, gait disturbance, musculoskeletal stiffness and NS expected arthralgia, vaccination site pain, vaccination site lymphadenopathy, headache.  Event onset the same day as first dose mRNA-1273. Outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
On 12/1/00 within hours of vax, he developed severe redness and swelling at the injection site. He also developed a moderate fever and moderate pain. On 12/2/00 he developed moderate swelling of his thigh. He recovered on 12/2/00 without treatment. The reporter considered the fever, pain and swollen thigh to be related to the Infanrix administration.
Developed redness around upper arm 2 d after vaccine given-Itchy c/o nausea- Rx BENADRYL, MOTRIN -Lasted 3-4 days.
experienced soreness at the injection site; This is a spontaneous report from a Non-contactable Consumer A female patient of an unspecified age started to receive bnt162b2 (BNT162B2) via an unspecified route of administration on an unspecified date at SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient experienced soreness at the injection site on an unspecified date with outcome of unknown. The action taken was not applicable. No follow-up attempts are possible, information about lot/batch cannot be obtained.
Severe local skin redness and induration that increased over 2 days after getting vaccine on 02/22/16. Likely early cellulitis.
Patient admitted 10/22/07 to 11/4/07 for mental status changes diagnosed with encephalitis.  MRI showed right temporal lobe signal c/w with HSV encephalitis. HSV testing was negative. Patient was treated with acyclovir and improved. 1/28/08-records received-presented to ED with C/O fall from his bicycle, witnesses indicated he just fell from bike. Acting strage with repetitive questioning and left sided weakness. Demonstrated left cerebellar functioning with corresponding ataxic gate. DX encephalitis.